2-Bromo-4-chloroaniline → 2-[(4-Boc-piperazin-1-ylcarbonyl)amino]-5-chlorobromobenzene

HRID 1247054

反応式

HRID 1247054 の反応式
Cl[C:2](Cl)([O:4]C(=O)OC(Cl)(Cl)Cl)Cl.[Br:13][C:14]1[CH:20]=[C:19]([Cl:21])[CH:18]=[CH:17][C:15]=1[NH2:16].C(N(CC)C(C)C)(C)C.[C:31]([N:38]1[CH2:43][CH2:42][NH:41][CH2:40][CH2:39]1)([O:33][C:34]([CH3:37])([CH3:36])[CH3:35])=[O:32]>ClCCl>[C:31]([N:38]1[CH2:39][CH2:40][N:41]([C:2]([NH:16][C:15]2[CH:17]=[CH:18][C:19]([Cl:21])=[CH:20][C:14]=2[Br:13])=[O:4])[CH2:42][CH2:43]1)([O:33][C:34]([CH3:37])([CH3:36])[CH3:35])=[O:32]

参加物

6

反応物 4

HCID 701102-Bromo-4-chloroanilineHCID 81531DiisopropylethylamineHCID 94429TriphosgeneHCID 143452tert-Butyl piperazine-1-carboxylate

生成物 1

HCID 219065382-[(4-Boc-piperazin-1-ylcarbonyl)amino]-5-chlorobromobenzene収率 191.1%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒3 回

実験手順

To a stirring solution of triphosgene (2.7 g, 9.0 mmol) in dichloromethane (100 mL) was added, dropwise via an addition funnel, a solution of 2-bromo-4-chloroaniline (5 g, 24.2 mmol) and N,N-diisopropylethylamine (6.9 g, 53.2 mmol) in dichloromethane (50 mL). After complete addition and an additional hour, a solution of N-Boc-piperazine (5 g, 26.6 mmol) in dichloromethane (50 mL) was added. After stirring overnight, the solvent was removed in vacuo and the residue was partitioned between ethyl acetate and water. The organic phase was separated and washed consecutively with 1 M citric acid, brine, sat. aq sodium bicarbonate and finally with brine, then dried with MgSO4, filtered and concentrated in vacuo. The residue was then dissolved in a minimal amount of chloroform and chromatographed over silica gel, eluting with 20% ethyl acetate in hexanes followed by 30% ethyl acetate in hexanes. The product containing fractions were combined and concentrated in vacuo and the resulting solid was suspended in diethyl ether, sonicated and then filtered and dried in vacuo to give 7.2 g (71%) of a white powder.

後処理

  1. additionAfter complete addition
  2. customthe solvent was removed in vacuo
  3. customthe residue was partitioned between ethyl acetate and water
  4. customThe organic phase was separated
  5. washwashed consecutively with 1 M citric acid, brine, sat. aq sodium bicarbonate and finally with brine
  6. dry with materialdried with MgSO4
  7. filtrationfiltered
  8. concentrationconcentrated in vacuo
  9. dissolutionThe residue was then dissolved in a minimal amount of chloroform
  10. customchromatographed over silica gel
  11. washeluting with 20% ethyl acetate in hexanes
  12. additionThe product containing fractions
  13. concentrationconcentrated in vacuo
  14. customsonicated
  15. filtrationfiltered
  16. customdried in vacuo

出典と根拠

ORDレコード
ord-02c2ef16fc854b0c837365bddf876291
出典データセット
uspto-grants-2006_10
特許番号
US07129245B2

関連ノート

読み込み中…